This work is licensed under the Creative Commons Attribution 4.0 International License.
Ellis ER, Josephson ME. What about tachycardia-induced cardiomyopathy?Arrhythm Electrophysiol Rev. 2013;2(2):82-90.EllisERJosephsonME.What about tachycardia-induced cardiomyopathy?Arrhythm Electrophysiol Rev.2013;2(2):82-90.Search in Google Scholar
Chugh SS, Shen WK, Luria DM, Smith HC. First evidence of premature ventricular complex-induced cardiomyopathy: a potentially reversible cause of heart failure.J Cardiovasc Electrophysiol. 2000;11(3):328-9. doi: 10.1111/ j.1540-8167.2000.tb01802.x. PMID: 10749356.ChughSSShenWKLuriaDMSmithHC.First evidence of premature ventricular complex-induced cardiomyopathy: a potentially reversible cause of heart failure.J Cardiovasc Electrophysiol.2000;11(3):328-9. doi:10.1111/j.1540-8167.2000.tb01802.x. PMID:10749356.Open DOISearch in Google Scholar
Luchsinger JA, Steinberg JS. Resolution of cardiomyopathy after ablation of atrial flutter.J Am Coll Cardiol. 1998;32(1):205-210.LuchsingerJASteinbergJS.Resolution of cardiomyopathy after ablation of atrial flutter.J Am Coll Cardiol.1998;32(1):205-210.Search in Google Scholar
Huizar JF, Ellenbogen KA, Tan AY, Kaszala K. Arrhythmia-induced cardiomyopathy: JACC state-of-the-art review.J Am Coll Cardiol. 2019;73(18):2328-2344. doi:10.1016/j.jacc.2019.02.045.HuizarJFEllenbogenKATanAYKaszalaK.Arrhythmia-induced cardiomyopathy: JACC state-of-the-art review.J Am Coll Cardiol.2019;73(18):2328-2344. doi:10.1016/j.jacc.2019.02.045.Open DOISearch in Google Scholar
Albakri A. Tachycardia-induced cardiomyopathy: a review of literature on clinical status and meta-analysis of diagnosis and clinical management method.Integr Mol Med. 2018;5(1). doi:10.15761/imm.1000324
AlbakriA.Tachycardia-induced cardiomyopathy: a review of literature on clinical status and meta-analysis of diagnosis and clinical management method.Integr Mol Med.2018;5(1). doi:10.15761/imm.1000324Open DOISearch in Google Scholar
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.HindricksGPotparaTDagresNArbeloEBaxJJBlomström-LundqvistC2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.Eur Heart J.2021Feb1;42(5):373-498. doi:10.1093/eurheartj/ehaa612.Open DOISearch in Google Scholar
Martin CA, Lambiase PD. Pathophysiology, diagnosis and treatment of tachycardiomyopathy.Heart. 2017;103(19):1543-1552. doi:10.1136/ heartjnl-2016-310391.MartinCALambiasePD.Pathophysiology, diagnosis and treatment of tachycardiomyopathy.Heart.2017;103(19):1543-1552. doi:10.1136/ heartjnl-2016-310391.Open DOISearch in Google Scholar
Perez-Silva A, Merino JL. Tachycardia-induced cardiomyopathy.E-J ESC Counc Cardiol Prac. 2009;7(16).Perez-SilvaAMerinoJL.Tachycardia-induced cardiomyopathy.E-J ESC Counc Cardiol Prac.2009;7(16).Search in Google Scholar
Ermert L, Kreimer F, Quast DR, Pflaumbaum A, Mügge A, Gotzmann M. Rate of atrial fibrillation and flutter induced tachycardiomyopathy in a cohort of hospitalized patients with heart failure and detection of indicators for improved diagnosis.Front Cardiovasc Med. 2023;9. doi:10.3389/fcvm.2022.940060.ErmertLKreimerFQuastDRPflaumbaumAMüggeAGotzmannM.Rate of atrial fibrillation and flutter induced tachycardiomyopathy in a cohort of hospitalized patients with heart failure and detection of indicators for improved diagnosis.Front Cardiovasc Med.2023;9. doi:10.3389/fcvm.2022.940060.Open DOISearch in Google Scholar
Jeong YH, Choi KJ, Song JM, Hwang ES, Park KM, Nam GB, et al. Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy.Clin Cardiol. 2008;31(4):172-178. doi:10.1002/clc.20161.JeongYHChoiKJSongJMHwangESParkKMNamGBDiagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy.Clin Cardiol.2008;31(4):172-178. doi:10.1002/clc.20161.Open DOISearch in Google Scholar
Umana E, Solares CA, Alpert MA. Tachycardia-induced cardiomyopathy.Am J Med. 2003;114(1):51-55. doi:10.1016/S0002-9343(02)01472-9.UmanaESolaresCAAlpertMA.Tachycardia-induced cardiomyopathy.Am J Med.2003;114(1):51-55. doi:10.1016/S0002-9343(02)01472-9.Open DOISearch in Google Scholar
Fujino T, Yamashita T, Suzuki S, Sugiyma H, Sagara K, Sawada H, et al. Characteristics of congestive heart failure accompanied by atrial fibrillation with special reference to tachycardia-induced cardiomyopathy.Circ J. 2007 Jun;71(6):936-40. doi: 10.1253/circj.71.936. PMID: 17526993.FujinoTYamashitaTSuzukiSSugiymaHSagaraKSawadaHCharacteristics of congestive heart failure accompanied by atrial fibrillation with special reference to tachycardia-induced cardiomyopathy.Circ J. 2007 Jun;71(6):936-40. doi:10.1253/circj.71.936. PMID:17526993.Open DOISearch in Google Scholar
Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al. Catheter ablation for atrial fibrillation with heart failure.N Engl J Med. 2018;378(5):417-427. doi:10.1056/nejmoa1707855.MarroucheNFBrachmannJAndresenDSiebelsJBoersmaLJordaensLCatheter ablation for atrial fibrillation with heart failure.N Engl J Med.2018;378(5):417-427. doi:10.1056/nejmoa1707855.Open DOISearch in Google Scholar
Dagres N, Varounis C, Gaspar T, Piorkowski C, Eitel C, Iliodromitis EK, et al. Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis.J Card Fail. 2011 Nov;17(11):964-70. doi: 10.1016/j.cardfail.2011.07.009.DagresNVarounisCGasparTPiorkowskiCEitelCIliodromitisEKCatheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis.J Card Fail.2011Nov;17(11):964-70. doi:10.1016/j.cardfail.2011.07.009.Open DOISearch in Google Scholar
Trulock KM, Narayan SM, Piccini JP. Rhythm control in heart failure patients with atrial fibrillation contemporary challenges including the role of ablation.J Am Coll Cardiol. 2014;64(7).TrulockKMNarayanSMPicciniJP.Rhythm control in heart failure patients with atrial fibrillation contemporary challenges including the role of ablation.J Am Coll Cardiol.2014;64(7).Search in Google Scholar
Aldaas OM, Malladi CL, Hsu JC. Catheter Ablation of atrial fibrillation in patients with heart failure.Am J Cardiol. 2019;123(1):187-195. doi:10.1016/j. amjcard.2018.09.013.AldaasOMMalladiCLHsuJC.Catheter Ablation of atrial fibrillation in patients with heart failure.Am J Cardiol.2019;123(1):187-195. doi:10.1016/j.amjcard.2018.09.013.Open DOISearch in Google Scholar
Katritsis G, Calkins H. Catheter ablation of atrial fibrillation-techniques and technology.Arrhythm Electrophysiol Rev. 2012:29-33.KatritsisGCalkinsH.Catheter ablation of atrial fibrillation-techniques and technology.Arrhythm Electrophysiol Rev.2012:29-33.Search in Google Scholar
Rabbani LE. Time course of improvement in ventricular function after ablation of incessant automatic atrial tachycardia.Am Heart J.1991;121(3):816-819.RabbaniLE.Time course of improvement in ventricular function after ablation of incessant automatic atrial tachycardia.Am Heart J.1991;121(3):816-819.Search in Google Scholar
Mohamed HA. Tachycardia-induced cardiomyopathy (tachycardiomyopathy).Libyan J Med. 2007;2(1):26-29. doi:10.3402/ljm. v2i1.4688
MohamedHA.Tachycardia-induced cardiomyopathy (tachycardiomyopathy).Libyan J Med.2007;2(1):26-29. doi:10.3402/ljm.v2i1.4688Open DOISearch in Google Scholar
Prabhu S, Costello BT, Taylor AJ, Gutman SJ, Voskoboinik A, McLellan AJA, et al. Regression of diffuse ventricular fibrosis following restoration of sinus rhythm with catheter ablation in patients with atrial fibrillation and systolic dysfunction: A substudy of the CAMERA MRI trial.JACC Clin Electrophysiol. 2018 Aug;4(8):999-1007. doi: 10.1016/j.jacep.2018.04.013.PrabhuSCostelloBTTaylorAJGutmanSJVoskoboinikAMcLellanAJARegression of diffuse ventricular fibrosis following restoration of sinus rhythm with catheter ablation in patients with atrial fibrillation and systolic dysfunction: A substudy of the CAMERA MRI trial.JACC Clin Electrophysiol.2018Aug;4(8):999-1007. doi:10.1016/j.jacep.2018.04.013.Open DOISearch in Google Scholar
Ling LH, Kistler PM, Ellims AH, Iles LM, Lee G, Hughes GL, et al. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction.J Am Coll Cardiol. 2012 Dec 11;60(23):2402-8. doi: 10.1016/j.jacc.2012.07.065.LingLHKistlerPMEllimsAHIlesLMLeeGHughesGLDiffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction.J Am Coll Cardiol.2012Dec11;60(23):2402-8. doi:10.1016/j.jacc.2012.07.065.Open DOISearch in Google Scholar